Developer docs
API playgroundTry for free, no card

Search company profiles

TINAVI

Full company profile

uuid0034zy6

Namestring
TINAVI
Legal namestring
Beijing Tinavi Medical Technologies Co., Ltd.
Websiteurl
en.tinavi.com
Company typeenum
Public
Founded yearint
2005
Descriptiontext

Beijing Tinavi Medical Technologies Co., Ltd. (TINAVI) is a Beijing-headquartered, publicly listed (SSE STAR Market, Code 688277, IPO date July 7, 2020) designer, manufacturer, and commercializer of orthopedic surgical robotic systems, founded in 2005 and operating for 19 years with a workforce of 101–250. Its core platform, the TiRobot family, integrates a six-axis robotic arm, an optical tracking system, and a main control surgical cart, and is reportedly the world's only orthopedic robot capable of performing spine, joint, and trauma procedures on a single device, with quoted clinical accuracy of 1 mm, radiation exposure reduction of about 70%, and surgical efficiency improvement of about 30%. The lineup includes the original TiRobot (launched 2016), TiRobot II (launched April 2021), TiRobot Recon (a total knee arthroplasty robot in NMPA innovative-device review since November 2020), a 5G Remote Surgery System, and bundled disposable instrument toolkits, plus the co-developed Viper Prime™&TiRobot integrated solution with Johnson & Johnson Medical.

TINAVI monetizes through high-value capital equipment sales to hospitals, recurring revenue from disposable precision tracking components and procedure-specific toolkits, and clinical training and maintenance services delivered through a direct enterprise sales force, supplemented by a strategic co-development and distribution partnership with Johnson & Johnson Medical signed in October 2019. The customer base consists of major tertiary hospitals and orthopedic surgery centers in China; the TiRobot system is deployed in 200+ medical institutions across 31 provincial-level regions and has supported 150,000+ cumulative surgeries as of Q1 2025. Distribution also reaches North America via CSA certification (December 2021) and the EU via CE MDR certification (August 2024), and a Robot Application Training Center network across hospitals including Renji, Qilu, Beijing Jishuitan, Anhui Medical University, and China Medical University supports surgeon enablement.

Beyond products, TINAVI operates a wholly-owned subsidiary, Beijing Medical Robot Industry Innovation Center, and jointly runs the Joint Intelligent Orthopaedic Lab with Beijing Jishuitan Hospital and the Beijing Orthopedic Robotic System Engineering Research Center with Beijing's municipal development authorities. Reimbursement coverage under Beijing Class A Medical Insurance (effective October 23, 2021) materially expands addressable demand within China. The company is led by Chairman Zhang Songgen and CEO Dr. Xu Jin, and has received national, regional, and international recognition including the Second Prize of the National Science and Technology Progress Award (2015) and coverage in Nature's special issue on medical robotics in China.

Short descriptiontext

Beijing Tinavi Medical Technologies Co., Ltd. is a publicly listed (SSE 688277) Chinese designer and manufacturer of orthopedic surgical robotic systems, including TiRobot and TiRobot II, serving 200+ hospitals across China with expanding access to North America and Europe via CSA and CE MDR certifications.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersBeijing, China
HQ citystring
Beijing
HQ countrystring
China
HQ regionstring
Asia
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
orthopedic surgical robots, surgical navigation systems, robotic-assisted surgery, medical robotics, orthopedic implants
Industry4 codes
PRIMARYHLAHADAF
Surgical Robotics & Computer-Assisted Surgery Platforms
Healthcare & Life Sciences/Medical Devices & Diagnostics/Surgical Instruments, Endoscopy & OR Equipment
SECONDARYHLAHAEAL
Surgical Navigation, Robotics & Patient-Matched Instrumentation (Ortho/Spine)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Implants & Prosthetics (Orthopedic/Neuro/Spine/Dental)
SECONDARYHDAAAIAC
Healthcare & Assistive Robotics
SECONDARYHLALAGAO
Orthopedics & Sports Medicine Telemedicine Platforms
Healthcare & Life Sciences/Telehealth Platforms/Specialty Telemedicine Platforms (e.g., dermatology, cardiology, neurology)
NAICS code4 codes
  • Surgical and Medical Instrument Manufacturing339112
  • Surgical Appliance and Supplies Manufacturing339113
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
  • Navigational, Measuring, Electromedical, and Control Instruments Manufacturing33451
SIC code3 codes
  • Orthopedic, Prosthetic & Surgical Appliances & Supplies3842
  • Surgical & Medical Instruments & Apparatus3841
  • Electromedical & Electrotherapeutic Apparatus3845
Product category
Orthopedic Surgical Robotics
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model3 records
1Orthopedic Surgical Robot Systems
TypeHardware Sales
Description

Sale of TiRobot orthopedic surgical robot systems to hospitals and medical institutions. Systems include robotic arm, optical tracking system, and main control surgical cart components along with compatible instruments.

en.tinavi.com
2Disposable and Optional Toolkits
TypeHardware Sales
Description

Sale of disposable precision tracking components, locating toolkits for various orthopedic procedures (spine, trauma, hand surgery, cervical surgery, hip surgery, foot & ankle surgery).

en.tinavi.com
3Clinical Support and Training Services
TypeProfessional Services
Description

Surgery observation, training services, clinical support for newly installed robots, and maintenance services provided to collaborative hospitals.

en.tinavi.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Personnel, Supply Chain, Operations, Marketing or Sales
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 4 records shown
1TiRobot
Description

Orthopedic robotic system for spinal and trauma surgery, featuring robotic arm, optical tracking system, and main control surgical cart for precise positioning.

en.tinavi.com
+3 more records
Core offering1 text field

TINAVI designs, manufactures, and sells orthopedic surgical robot systems (TiRobot family) and related disposable instruments for use in spine, trauma, and joint surgeries. The company sells its robotic platforms, including the TiRobot and TiRobot II systems, along with procedure-specific locating toolkits and complementary services such as clinical training, remote surgery platforms, and maintenance to hospitals and medical institutions.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • Surgical accuracy reaches 1mm
+4 more records
Product overview1 text field

TINAVI offers a unified orthopedic robotic surgery platform centered on the TiRobot product family, including TiRobot II (latest generation, launched 2021) and TiRobot Orthopaedic Robotic System (original generation, launched 2016), both serving as the core surgical robot systems capable of spinal, trauma, and joint surgeries. The product portfolio also includes TiRobot Instruments (disposable and optional toolkits for specific surgical types), the 5G Remote Surgery System (remote consultation and tele-surgery platform), TiRobot Recon (total knee arthroplasty module), and Viper PrimeTM&TiRobot (joint integrated implant solution with Johnson & Johnson). All TiRobot systems share a common architecture combining optical tracking, robotic arm positioning, and main control surgical cart. TINAVI College provides the educational and training platform for surgeons using these systems.

Product and service1 record
1TiRobot Orthopaedic Robotic System (TiRobot®)
CategoryOrthopedic Surgical Robot
Scale indicator8 records

Each record includes

Type, Value, Description, Source

Partnership15 partners
1Shandong Weigao
Strategic tierMinorTypeStrategic or Co-development PartnerAnnounced on2022-01-01
Description

TINAVI and Shandong Weigao signed strategic agreement for orthopedic market collaboration.

en.tinavi.com
2The First Hospital of China Medical University
Strategic tierFlagshipTypeImplementation/ SI/ Consulting PartnerAnnounced on2021-12-01
Description

Joint establishment of Robot Application Training Center for orthopedic robot training programs.

en.tinavi.com
Strategic tierFlagshipTypeStrategic or Co-development PartnerAnnounced on2021-11-01
Description

Joint development of Viper PrimeTM&TiRobot integrated surgical treatment combining TiRobot with J&J's Viper PrimeTM minimally invasive implant system for enhanced spinal surgery solutions.

4Tianjin Hospital
Strategic tierFlagshipTypeImplementation/ SI/ Consulting PartnerAnnounced on2021-10-01
Description

Strategic cooperation agreement signed for robot surgery skills training courses.

en.tinavi.com
5Fujian Provincial Hospital
Strategic tierFlagshipTypeImplementation/ SI/ Consulting PartnerAnnounced on2021-10-01
Description

Strategic cooperation agreement signed for robot surgery skills training courses.

en.tinavi.com
6Jiangsu Provincial Hospital
Strategic tierFlagshipTypeImplementation/ SI/ Consulting PartnerAnnounced on2021-10-01
Description

Strategic cooperation agreement signed for robot surgery skills training courses.

en.tinavi.com
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2021-09-01
Description

Joint creation of Joint Intelligent Orthopaedic Lab with agreement including patent transfer, establishment of intelligent orthopaedics research fund and joint laboratory for orthopaedic surgical robot transformation.

8Beijing Municipal Development and Reform Commission
Strategic tierCoreTypeOthersAnnounced on2021-09-01
Description

Jointly declared construction plan of Beijing Orthopedic Robotic System Engineering Research Center by Beijing Jishuitan Hospital, TINAVI and another medical company. Approved to operate as independent legal entity working as innovative platform driven by clinical requirements.

en.tinavi.com
9The First Hospital of Anhui Medical University
Strategic tierFlagshipTypeImplementation/ SI/ Consulting PartnerAnnounced on2021-07-01
Description

Joint establishment of Robot Application Training Center where experts introduced clinical application of TiRobot in spine, trauma, limbs.

en.tinavi.com
10Guangdong Provincial Hospital of Chinese Medicine (Zhuhai)
Strategic tierCoreTypeImplementation/ SI/ Consulting PartnerAnnounced on2021-01-06
Description

Orthopaedic surgical robot project kicked off marking TiRobot settling in Zhuhai and being put into clinical application.

en.tinavi.com
11Beijing Medical Robot Industry Innovation Center
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2020-12-28
Description

TINAVI's holding subsidiary organizing 3rd International Forum on Innovation and Development of Medical Robot 2020. Strategic cooperation agreement signed with Chinese Society of Biomedical Engineering to build medical robot technology innovation cluster.

en.tinavi.com
Strategic tierFlagshipTypeImplementation/ SI/ Consulting PartnerAnnounced on2020-12-13
Description

Joint establishment of Robot-assisted Spinal Surgery Training Center providing Preliminary and Advanced Robot-assisted Spinal Surgery Skills Training Programs for surgeons throughout the province and country.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2020-12-09
Description

Opened Joint Intelligent Orthopaedic Lab and signed agreement on transformation of orthopaedic surgical robot including patent transfer, intelligent orthopaedics research fund, and joint laboratory.

14Renji Hospital of Shanghai Jiaotong University School of Medicine
Strategic tierFlagshipTypeImplementation/ SI/ Consulting PartnerAnnounced on2020-10-31
Description

Strategic cooperation for opening of Robot-assisted Spinal Surgery Skills Training Program and inauguration of Robot-assisted Spinal Surgery Clinical Technology Application Center at Showsite Center, strengthening advantages and surgical skills in eastern China.

en.tinavi.com
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2019-10-23
Description

TINAVI and J&J signed agreement on joint R&D, cooperative marketing and distribution. Through this cooperation, TINAVI's surgical robots combined with J&J's orthopedic implants deliver superior digital surgical treatment solutions to Chinese patients and globally. The partnership also includes doctor training programs and joint robot-assisted spinal surgery skills training centers at major hospitals.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Intuitive Surgical's da Vinci platform dominates surgical robotics broadly (general surgery, urology, gynecology) and is the broad incumbent reference for any surgical robotics business. Comparable on robotic surgery platform economics, recurring instrument revenue, and surgeon-training-driven adoption, though not directly competing in orthopedics.

TypeDirect peer
Description

Medtronic's Mazor robotic spine surgery platform (acquired from Mazor Robotics) is a direct competitor to TiRobot in spine surgical robotics. Both target hospitals with capital-equipment sales models and disposable instrument revenue streams.

TypeEmerging player
Description

Brainlab provides surgical navigation, planning, and mixed-reality surgical platforms with growing robotics exposure (e.g., Loop-X). Comparable in surgical navigation and image-guided orthopedic workflows as an emerging technology competitor.

TypeDirect peer
Description

NuVasive's Pulse surgical automation and robotics platform competes in spine surgical robotics. Comparable business model focused on spine enabling-technology sales to hospitals with surgeon-training-driven adoption.

TypeDirect peer
Description

Globus Medical's ExcelsiusGPS robotic navigation platform competes directly with TiRobot in spine surgical robotics. Both emphasize real-time tracking, robotic arm positioning, and navigation in spine and trauma orthopedic procedures.

TypeDirect peer
Description

Stryker's Mako robotic-arm assisted surgery platform is the global market leader in orthopedic surgical robotics for knee, hip, and spine. Directly comparable to TINAVI's TiRobot as the dominant global incumbent competing for the same hospital orthopedic surgical robotics budgets.

7Johnson & Johnson (DePuy Synthes / Velys)
TypeDirect peer
Description

J&J's Velys robotic-assisted surgery platform for knee and integrated Viper Prime™&TiRobot partnership make J&J both a partner and a competitor. Comparable as a strategic orthopedic implant + robotics bundling competitor targeting the same Chinese and global hospital customers.

TypeRegional player
Description

MicroPort's MedBot develops surgical robotics including orthopedic applications (e.g., Honghu, Jianzhong). Comparable as a Chinese-listed domestic competitor in surgical robotics, though TINAVI's orthopedic focus and 19-year orthopedic track record differentiate it from MedBot's broader specialty mix.

TypeDirect peer
Description

Smith+Nephew's CORI handheld robotic-assisted surgical system for knee arthroplasty competes directly with TiRobot Recon. Both target orthopedic procedure robotics with handheld/portable form factors, though TINAVI's full-platform approach extends beyond knee.

TypeEmerging player
Description

Renishaw's Neuromate and neurosurgical robot platforms represent an emerging player in surgical robotics with overlap on the technology side (precision robotic positioning, navigation). Less direct overlap with TINAVI as Neuromate is neurosurgical rather than orthopedic.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers7 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration3 records

Each record includes

Title, Type, Description, Source

AI capability6 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance5 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment3 records

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

TINAVI

Orthopedic Surgical Roboticsen.tinavi.com

Beijing Tinavi Medical Technologies Co., Ltd. is a publicly listed (SSE 688277) Chinese designer and manufacturer of orthopedic surgical robotic systems, including TiRobot and TiRobot II, serving 200+ hospitals across China with expanding access to North America and Europe via CSA and CE MDR certifications.

What TINAVI does

Beijing Tinavi Medical Technologies Co., Ltd. (TINAVI) is a Beijing-headquartered, publicly listed (SSE STAR Market, Code 688277, IPO date July 7, 2020) designer, manufacturer, and commercializer of orthopedic surgical robotic systems, founded in 2005 and operating for 19 years with a workforce of 101–250. Its core platform, the TiRobot family, integrates a six-axis robotic arm, an optical tracking system, and a main control surgical cart, and is reportedly the world's only orthopedic robot capable of performing spine, joint, and trauma procedures on a single device, with quoted clinical accuracy of 1 mm, radiation exposure reduction of about 70%, and surgical efficiency improvement of about 30%. The lineup includes the original TiRobot (launched 2016), TiRobot II (launched April 2021), TiRobot Recon (a total knee arthroplasty robot in NMPA innovative-device review since November 2020), a 5G Remote Surgery System, and bundled disposable instrument toolkits, plus the co-developed Viper Prime™&TiRobot integrated solution with Johnson & Johnson Medical.

TINAVI monetizes through high-value capital equipment sales to hospitals, recurring revenue from disposable precision tracking components and procedure-specific toolkits, and clinical training and maintenance services delivered through a direct enterprise sales force, supplemented by a strategic co-development and distribution partnership with Johnson & Johnson Medical signed in October 2019. The customer base consists of major tertiary hospitals and orthopedic surgery centers in China; the TiRobot system is deployed in 200+ medical institutions across 31 provincial-level regions and has supported 150,000+ cumulative surgeries as of Q1 2025. Distribution also reaches North America via CSA certification (December 2021) and the EU via CE MDR certification (August 2024), and a Robot Application Training Center network across hospitals including Renji, Qilu, Beijing Jishuitan, Anhui Medical University, and China Medical University supports surgeon enablement.

Beyond products, TINAVI operates a wholly-owned subsidiary, Beijing Medical Robot Industry Innovation Center, and jointly runs the Joint Intelligent Orthopaedic Lab with Beijing Jishuitan Hospital and the Beijing Orthopedic Robotic System Engineering Research Center with Beijing's municipal development authorities. Reimbursement coverage under Beijing Class A Medical Insurance (effective October 23, 2021) materially expands addressable demand within China. The company is led by Chairman Zhang Songgen and CEO Dr. Xu Jin, and has received national, regional, and international recognition including the Second Prize of the National Science and Technology Progress Award (2015) and coverage in Nature's special issue on medical robotics in China.

TINAVI firmographics

Firmographics
Name
TINAVI
Legal name
Beijing Tinavi Medical Technologies Co., Ltd.
Website
https://en.tinavi.com
Company type
Public
Founded year
2005
Operating status
Operating
Headcount range
101–250 employees
Short description
Beijing Tinavi Medical Technologies Co., Ltd. is a publicly listed (SSE 688277) Chinese designer and manufacturer of orthopedic surgical robotic systems, including TiRobot and TiRobot II, serving 200+ hospitals across China with expanding access to North America and Europe via CSA and CE MDR certifications.
Ownership category
akta.pro rank

TINAVI industry classification

Industry
Product category
Orthopedic Surgical Robotics
NAICS
Surgical and Medical Instrument Manufacturing (339112), Surgical Appliance and Supplies Manufacturing (339113), Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (33451)
SIC
Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842), Surgical & Medical Instruments & Apparatus (3841), Electromedical & Electrotherapeutic Apparatus (3845)
akta.pro industry
PRIMARYHLAHADAF
Surgical Robotics & Computer-Assisted Surgery Platforms
Healthcare & Life Sciences/Medical Devices & Diagnostics/Surgical Instruments, Endoscopy & OR Equipment
SECONDARYHLAHAEAL
Surgical Navigation, Robotics & Patient-Matched Instrumentation (Ortho/Spine)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Implants & Prosthetics (Orthopedic/Neuro/Spine/Dental)
SECONDARYHDAAAIAC
Healthcare & Assistive Robotics
SECONDARYHLALAGAO
Orthopedics & Sports Medicine Telemedicine Platforms
Healthcare & Life Sciences/Telehealth Platforms/Specialty Telemedicine Platforms (e.g., dermatology, cardiology, neurology)

Keywords

  • Orthopedic surgical robots
  • Surgical navigation systems
  • Robotic-assisted surgery
  • Medical robotics
  • Orthopedic implants

Where TINAVI is headquartered

Location

Headquarters

HQ city
Beijing
HQ country
China
HQ region
Asia

Offices1 record

Markets served

TINAVI business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Personnel, Supply Chain, Operations, Marketing or Sales

Revenue model

  1. Orthopedic Surgical Robot Systems: Sale of TiRobot orthopedic surgical robot systems to hospitals and medical institutions. Systems include robotic arm, optical tracking system, and main control surgical cart components along with compatible instruments.
  2. Disposable and Optional Toolkits: Sale of disposable precision tracking components, locating toolkits for various orthopedic procedures (spine, trauma, hand surgery, cervical surgery, hip surgery, foot & ankle surgery).
  3. Clinical Support and Training Services: Surgery observation, training services, clinical support for newly installed robots, and maintenance services provided to collaborative hospitals.

Go-to-market motion2 records

Distribution channels4 records

Marketing channels5 records

TINAVI product offering

Product offering

Core offering

TINAVI designs, manufactures, and sells orthopedic surgical robot systems (TiRobot family) and related disposable instruments for use in spine, trauma, and joint surgeries. The company sells its robotic platforms, including the TiRobot and TiRobot II systems, along with procedure-specific locating toolkits and complementary services such as clinical training, remote surgery platforms, and maintenance to hospitals and medical institutions.

Product overview

TINAVI offers a unified orthopedic robotic surgery platform centered on the TiRobot product family, including TiRobot II (latest generation, launched 2021) and TiRobot Orthopaedic Robotic System (original generation, launched 2016), both serving as the core surgical robot systems capable of spinal, trauma, and joint surgeries. The product portfolio also includes TiRobot Instruments (disposable and optional toolkits for specific surgical types), the 5G Remote Surgery System (remote consultation and tele-surgery platform), TiRobot Recon (total knee arthroplasty module), and Viper PrimeTM&TiRobot (joint integrated implant solution with Johnson & Johnson). All TiRobot systems share a common architecture combining optical tracking, robotic arm positioning, and main control surgical cart. TINAVI College provides the educational and training platform for surgeons using these systems.

Differentiator

Problem solved

Functional benefit

Brands

  • TiRobot: Orthopedic robotic system for spinal and trauma surgery, featuring robotic arm, optical tracking system, and main control surgical cart for precise positioning.
  • TiRobot II
  • 5G Remote Surgery System
  • TINAVI College

Products and services

  • TiRobot Orthopaedic Robotic System (TiRobot®)

Quantifiable outcome

  • Surgical accuracy reaches 1mm
  • +4 more outcomes

Companies that use TINAVI

Customer profile

Named customers7 records

Segments3 records

Ideal customer profiles3 records

TINAVI technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration3 records

AI capability6 records

Feature6 records

TINAVI partnerships and signals

Strategic signal

Partnerships

15 partnerships are on record, tiered minor, flagship and core.

  • Shandong WeigaominorStrategic or Co-development Partner · 1 January 2022TINAVI and Shandong Weigao signed strategic agreement for orthopedic market collaboration.
  • The First Hospital of China Medical UniversityflagshipImplementation/ SI/ Consulting Partner · 1 December 2021Joint establishment of Robot Application Training Center for orthopedic robot training programs.
  • Johnson & Johnson (Viper Prime)flagshipStrategic or Co-development Partner · 1 November 2021Joint development of Viper PrimeTM&TiRobot integrated surgical treatment combining TiRobot with J&J's Viper PrimeTM minimally invasive implant system for enhanced spinal surgery solutions.
  • Tianjin HospitalflagshipImplementation/ SI/ Consulting Partner · 1 October 2021Strategic cooperation agreement signed for robot surgery skills training courses.
  • Fujian Provincial HospitalflagshipImplementation/ SI/ Consulting Partner · 1 October 2021Strategic cooperation agreement signed for robot surgery skills training courses.
  • Jiangsu Provincial HospitalflagshipImplementation/ SI/ Consulting Partner · 1 October 2021Strategic cooperation agreement signed for robot surgery skills training courses.
  • Beijing Jishuitan HospitalcoreStrategic or Co-development Partner · 1 September 2021Joint creation of Joint Intelligent Orthopaedic Lab with agreement including patent transfer, establishment of intelligent orthopaedics research fund and joint laboratory for orthopaedic surgical robot transformation.
  • Beijing Municipal Development and Reform CommissioncoreOthers · 1 September 2021Jointly declared construction plan of Beijing Orthopedic Robotic System Engineering Research Center by Beijing Jishuitan Hospital, TINAVI and another medical company. Approved to operate as independent legal entity working as innovative platform driven by clinical requirements.
  • The First Hospital of Anhui Medical UniversityflagshipImplementation/ SI/ Consulting Partner · 1 July 2021Joint establishment of Robot Application Training Center where experts introduced clinical application of TiRobot in spine, trauma, limbs.
  • Guangdong Provincial Hospital of Chinese Medicine (Zhuhai)coreImplementation/ SI/ Consulting Partner · 6 January 2021Orthopaedic surgical robot project kicked off marking TiRobot settling in Zhuhai and being put into clinical application.
  • Beijing Medical Robot Industry Innovation CentercoreStrategic or Co-development Partner · 28 December 2020TINAVI's holding subsidiary organizing 3rd International Forum on Innovation and Development of Medical Robot 2020. Strategic cooperation agreement signed with Chinese Society of Biomedical Engineering to build medical robot technology innovation cluster.
  • Qilu Hospital of Shandong UniversityflagshipImplementation/ SI/ Consulting Partner · 13 December 2020Joint establishment of Robot-assisted Spinal Surgery Training Center providing Preliminary and Advanced Robot-assisted Spinal Surgery Skills Training Programs for surgeons throughout the province and country.
  • Beijing Jishuitan HospitalcoreStrategic or Co-development Partner · 9 December 2020Opened Joint Intelligent Orthopaedic Lab and signed agreement on transformation of orthopaedic surgical robot including patent transfer, intelligent orthopaedics research fund, and joint laboratory.
  • Renji Hospital of Shanghai Jiaotong University School of MedicineflagshipImplementation/ SI/ Consulting Partner · 31 October 2020Strategic cooperation for opening of Robot-assisted Spinal Surgery Skills Training Program and inauguration of Robot-assisted Spinal Surgery Clinical Technology Application Center at Showsite Center, strengthening advantages and surgical skills in eastern China.
  • Johnson & Johnson MedicalcoreStrategic or Co-development Partner · 23 October 2019TINAVI and J&J signed agreement on joint R&D, cooperative marketing and distribution. Through this cooperation, TINAVI's surgical robots combined with J&J's orthopedic implants deliver superior digital surgical treatment solutions to Chinese patients and globally. The partnership also includes doctor training programs and joint robot-assisted spinal surgery skills training centers at major hospitals.

Scale indicators8 records

Recent moves7 records

Expansion highlights5 records

TINAVI competitors and assessment

Company assessment

Broad incumbents

  • Intuitive Surgical: Intuitive Surgical's da Vinci platform dominates surgical robotics broadly (general surgery, urology, gynecology) and is the broad incumbent reference for any surgical robotics business. Comparable on robotic surgery platform economics, recurring instrument revenue, and surgeon-training-driven adoption, though not directly competing in orthopedics.

Direct peers

  • Medtronic: Medtronic's Mazor robotic spine surgery platform (acquired from Mazor Robotics) is a direct competitor to TiRobot in spine surgical robotics. Both target hospitals with capital-equipment sales models and disposable instrument revenue streams.
  • NuVasive: NuVasive's Pulse surgical automation and robotics platform competes in spine surgical robotics. Comparable business model focused on spine enabling-technology sales to hospitals with surgeon-training-driven adoption.
  • Globus Medical: Globus Medical's ExcelsiusGPS robotic navigation platform competes directly with TiRobot in spine surgical robotics. Both emphasize real-time tracking, robotic arm positioning, and navigation in spine and trauma orthopedic procedures.
  • Stryker: Stryker's Mako robotic-arm assisted surgery platform is the global market leader in orthopedic surgical robotics for knee, hip, and spine. Directly comparable to TINAVI's TiRobot as the dominant global incumbent competing for the same hospital orthopedic surgical robotics budgets.
  • Johnson & Johnson (DePuy Synthes / Velys): J&J's Velys robotic-assisted surgery platform for knee and integrated Viper Prime™&TiRobot partnership make J&J both a partner and a competitor. Comparable as a strategic orthopedic implant + robotics bundling competitor targeting the same Chinese and global hospital customers.
  • Smith+Nephew: Smith+Nephew's CORI handheld robotic-assisted surgical system for knee arthroplasty competes directly with TiRobot Recon. Both target orthopedic procedure robotics with handheld/portable form factors, though TINAVI's full-platform approach extends beyond knee.

Emerging players

  • Brainlab: Brainlab provides surgical navigation, planning, and mixed-reality surgical platforms with growing robotics exposure (e.g., Loop-X). Comparable in surgical navigation and image-guided orthopedic workflows as an emerging technology competitor.
  • Renishaw: Renishaw's Neuromate and neurosurgical robot platforms represent an emerging player in surgical robotics with overlap on the technology side (precision robotic positioning, navigation). Less direct overlap with TINAVI as Neuromate is neurosurgical rather than orthopedic.

Regional players

  • MicroPort (Shanghai MicroPort MedBot): MicroPort's MedBot develops surgical robotics including orthopedic applications (e.g., Honghu, Jianzhong). Comparable as a Chinese-listed domestic competitor in surgical robotics, though TINAVI's orthopedic focus and 19-year orthopedic track record differentiate it from MedBot's broader specialty mix.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

TINAVI social profiles

Digital presence

TINAVI compliance and trust

Trust signal

Compliance5 records

TINAVI financial estimates

Financial estimate

Revenue estimate

Valuation estimate

TINAVI leadership team

Management profile

Number of profiles

Profiles2 records

TINAVI subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

TINAVI funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

TINAVI M&A and investment

M&A and investment

M&A

Investments3 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about TINAVI

What does TINAVI do?

TINAVI designs, manufactures, and sells orthopedic surgical robot systems (TiRobot family) and related disposable instruments for use in spine, trauma, and joint surgeries. The company sells its robotic platforms, including the TiRobot and TiRobot II systems, along with procedure-specific locating toolkits and complementary services such as clinical training, remote surgery platforms, and maintenance to hospitals and medical institutions.

Is TINAVI a public or private company?

TINAVI is a public company. It is classified as public and is currently operating.

When was TINAVI founded?

TINAVI was founded in 2005. It employs 101 to 250 people.

Where is TINAVI based?

TINAVI is headquartered in Beijing, China, in the Asia region.

How does TINAVI make money?

Three revenue lines are on record. Orthopedic Surgical Robot Systems are the primary driver. The others are disposable and Optional Toolkits and clinical Support and Training Services.

Who are TINAVI's main competitors?

Intuitive Surgical is listed as a broad incumbent. Direct peers are Medtronic, NuVasive, Globus Medical, Stryker, Johnson & Johnson (DePuy Synthes / Velys) and Smith+Nephew. Emerging players are Brainlab and Renishaw. MicroPort (Shanghai MicroPort MedBot) is listed as a regional player.

Does TINAVI have an API?

No public API is recorded for TINAVI.

What industry is TINAVI in?

TINAVI's product category is Orthopedic Surgical Robotics. Its primary akta.pro industry code is HLAHADAF, Surgical Robotics & Computer-Assisted Surgery Platforms, with a secondary code of HLAHAEAL, Surgical Navigation, Robotics & Patient-Matched Instrumentation (Ortho/Spine). Its NAICS code is 339112 and its SIC code is 3842.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
BiggoSurgical Robot Financing Plummets 70%: After the Capital Retreat, Who Survives on Surgical Volume? — BigGo FinanceChina's surgical robot industry is undergoing a severe capital retreat with financing deals dropping 70% from 2021 to 2024, forcing companies like TINAVI and Sinovation Medical to pursue IPOs or strategic acquisitions for survival. TINAVI announced a restructuring plan to acquire orthopedic implant assets, shifting its business model from equipment sales to an 'equipment + consumables' strategy to generate recurring revenue. Despite this pivot, the sector faces significant challenges as profitability remains elusive and clinical value validation is still required.PR NewswireThe Future of Surgical Robotics: Exploring Advanced Supply Chains and Manufacturing at 2026 MedtecMultiple market research firms project the global surgical robotics market will grow from approximately $11–12 billion in 2024/2025 to $23–29 billion by 2030, with Asia-Pacific (particularly China, Japan, South Korea, and India) identified as the fastest-growing region while North America retains its position as the largest market at 60–65% share. Intuitive Surgical reported strong Q1 2026 results with $2.77 billion in revenue (23% year-on-year increase) and 431 da Vinci system installations globally, while other major players including MicroPort MedBot, Jingfeng Medical, and Tinavi reported significant growth metrics. The article previews the 2026 Medtec medical device supply chain exhibition in Shanghai as a platform for surgical robotics companies to connect with upstream supply chain partners including precision transmissions, micro-sensors, AI chips, and specialized consumables.FutunnFocus: Industry breakthrough as surgical robots are assigned charging standards.China's National Healthcare Security Administration has issued nationwide pricing guidelines for surgical robot auxiliary operations, replacing the previous fragmented regional pricing system with a coefficient-based model linked to the primary surgery based on clinical participation levels. The move addresses longstanding ambiguity in charging standards where the same surgery could differ by over 30% across regions, providing hospitals with clear procurement criteria and accelerating market entry for surgical robots. China's surgical robot market grew from RMB 2.715 billion in 2019 to RMB 7.184 billion in 2024 and is projected to reach RMB 102.019 billion by 2033, with domestic manufacturers like MicroPort Robot and Tinavi Medical Technologies increasingly surpassing imported brands in most segments.openPR.comSurgical Robots Market 2025: Advanced Materials, Industry Demand, and Global Growth Forecast | Stryker, TINA VI Medical Technologies, Perfint HealthcareQY Research published a report on the global surgical robots market, projecting growth from $3.576 billion in 2024 to $12.6 billion by 2031, a 20% CAGR. The report covers segmentation by type and application, regional analysis, and key players including Stryker, TINA VI, and Perfint Healthcare.NatureCutting-edge surgical innovationBeijing-based TINAVI Medical Technologies is enhancing its collaboration with academic, clinical, and business partners to improve its TIANJI®Robot, China’s first home-grown orthopaedic surgical robot. The company has partnered with Johnson & Johnson for co-marketing, distribution, and R&D to bring the robotic solutions to the Chinese market, aiming to reduce surgical risks and improve patient outcomes through minimally invasive procedures.PR NewswireThe Global Medical Robotics Conference 2023: A Deep Dive into China's Booming Surgical Robotics LandscapeThe Global Medical Robotics Conference 2023 will be held in Beijing on September 8, 2023, organized by MedRobot and Leaderobot, bringing together top executives from China's three listed surgical robotics companies (MedBot, Tinavi, Sagebot) and global giants like Medtronic and Siemens. China's surgical robotics sector has grown remarkably, with over 80 startups emerging in the past three years and more than 8 billion RMB raised in the last year alone. The conference will feature presentations from more than 12 innovative companies and research institutions, covering topics from orthopedic and laparoscopic robots to ophthalmic and dental applications.BenzingaShenzhen Edge Medical Seeks Place in China's Surgical Robot Market - Intuitive Surgical (NASDAQ:ISRG)Shenzhen Edge Medical Co. Ltd. has applied for a Hong Kong IPO, with the company specializing in laparoscopic surgical robots and having two main products in advanced development stages: the MP1000, which completed urology clinical trials and had its registration accepted by China's NMPA, and the SP1000, China's first single-port surgical robot to reach clinical trial milestone. The company faces an uphill battle competing against established players including Intuitive Surgical's dominant Da Vinci system, as well as domestic rivals Shanghai MicroPort MedBot, Shandong Weigao Group, and Tinavi Medical Technologies, all of which already have approved products on the market. Despite raising over 2 billion yuan from investors including Sequoia Capital and Temasek, achieving a valuation exceeding $1.5 billion, Shenzhen Edge Medical logged 79.4 million yuan and 350 million yuan in net losses in 2020 and 2021 respectively, with the broader market constrained by high robot costs, lack of insurance coverage, and limited doctor training.NatureNational hub to accelerate robotics growthBeijing Medical Robotics Industry Innovation Center (IMC) was established in 2017 to accelerate medical robotics R&D and commercialization. It partners with TINAVI, Tsinghua, and the Beijing government, offering policy guidance, technical resources, and capital. IMC has hosted over 10 project teams worldwide.GlobeNewswireSPINEWAY : Increase in capital of €1.4 million and entry of TINAVI Medical Technologies into Spineway's capitalSpineway increased its capital by €1.4 million through the issuance of 355,260 new shares with attached warrants, paid entirely by TINAVI Medical Technologies. TINAVI now holds 9.09% of capital and 5.04% of voting rights. The partnership aims to support Spineway's development in China under its Skyway 2018 plan.